Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTK vs Cold Blood Cardioplegia in Tetralogy of Fallot Repair
NCT05176782Phase 1Unknown
- Sponsor
- Ain Shams University
- Start
- Dec 2021
- Primary completion
- Mar 2022
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised trial of HTK Custodiol in tetralogy of Fallot (TOF) (2 arms), sponsored by Ain Shams University. Primary endpoint: Vasoactive-Inotropic Score at 24 hours. Status: unknown.
02
Drugs
HTK Custodiol
03
Conditions
tetralogy of Fallot (TOF)
Beyond the preview
Go deeper on NCT05176782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05176782.